@ARTICLE{
author={Mistry Pramod K,...,Petakov Milan S,...,(broj koautora 18)},
year={2021},
title={Clinical outcomes after 4.5 years of eliglustat therapy for Gaucher disease type 1: Phase 3 ENGAGE trial final results},
journal={AMERICAN JOURNAL OF HEMATOLOGY},
volume={96},
number={9},
pages={1156-1165},
document_type={Article},
} 

@ARTICLE{
author={Mistry Pramod K,...,Petakov Milan S,...,(broj koautora 18)},
year={2020},
title={Individual patient responses to eliglustat in treatment-naive adults with Gaucher disease type 1: Final data from the phase 3 ENGAGE trial},
journal={MOLECULAR GENETICS AND METABOLISM},
volume={129},
number={2},
pages={S110-S111},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Mistry Pramod K,...,Petakov Milan S,...,(broj koautora 26)},
year={2019},
title={Addendum to Letter to the Editor: Safety, efficacy, and authorization of eliglustat as a first-line therapy in Gaucher disease type 1},
journal={BLOOD CELLS MOLECULES AND DISEASES},
volume={77},
number={},
pages={101-102},
document_type={Letter},
} 

@ARTICLE{
author={Mistry Pramod K,...,Petakov Milan S,...,(broj koautora 26)},
year={2018},
title={Safety, efficacy, and authorization of eliglustat as a first-line therapy in Gaucher disease type 1},
journal={BLOOD CELLS MOLECULES AND DISEASES},
volume={71},
number={},
pages={71-74},
document_type={Letter},
} 

@ARTICLE{
author={Mistry Pramod K,...,Petakov Milan S,...,(broj koautora 18)},
year={2017},
title={Outcomes after 18 months of eliglustat therapy in treatment-naive adults with Gaucher disease type 1: The phase 3 ENGAGE trial},
journal={AMERICAN JOURNAL OF HEMATOLOGY},
volume={92},
number={11},
pages={1170-1176},
document_type={Article},
} 

@ARTICLE{
author={Mistry Pramod K,...,Petakov Milan S,...,(broj koautora 18)},
year={2017},
title={Long-term results of ENGAGE: a phase 3, randomized, double blind, placebo-controlled, multi center study investigating the efficacy and safety of eliglustat in adults with type 1 Gaucher disease},
journal={MOLECULAR GENETICS AND METABOLISM},
volume={120},
number={1-2},
pages={S97-S98},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Mistry Pramod K,...,Petakov Milan S,...,(broj koautora 21)},
year={2015},
title={Effect of Oral Eliglustat on Splenomegaly in Patients With Gaucher Disease Type 1 The ENGAGE Randomized Clinical Trial},
journal={JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION},
volume={313},
number={7},
pages={695-706},
document_type={Article},
} 

@ARTICLE{
author={Mistry Pramod K,Lukina Elena,Ben Dridi Marie-Francoise,Amato Dominick J,Baris Hagit,Dasouki Majed,Ghosn Marwan,Mehta Atul,Packman Seymour,Pastores Gregory M,Petakov Milan S,Peterschmitt Judith M},
year={2013},
title={A phase 3, randomized, double-blind, placebo-controlled, multi-center study to investigate the efficacy and safety of eliglustat in patients with Gaucher disease type 1 (ENGAGE): Results after 9 months of treatment},
journal={MOLECULAR GENETICS AND METABOLISM},
volume={108},
number={2},
pages={S66-S67},
document_type={Meeting Abstract},
}